FIELD: clinical pharmacology. SUBSTANCE: invention relates with the use of the known compound 2,6-dimethyl-3,5-bis-(2-ethoxyhydroxycarbonyl)-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine at new appointing. Proposed agent can be used for oxygen supply damage treatment. EFFECT: increased activity of agents decreasing hemoglobin affinity to oxygen. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SELECTING PREPARATIONS THAT ENHANCE BRAUN OXYGEN SUPPLY | 0 |
|
SU1711069A1 |
| METHOD FOR DETERMINING MIXED HUMAN VENOUS BLOOD OXYGEN SATURATION MEAN VALUE | 2004 |
|
RU2275630C2 |
| METHOD OF PREPARING THE ARTIFICIAL OXYGEN CARRIER | 1990 |
|
RU2072853C1 |
| METHOD FOR DETECTING CARDIAC CORONARY RESERVE | 2004 |
|
RU2265852C2 |
| METHOD FOR ESTIMATING GENERAL PERIPHERAL PULMONARY CIRCULATION RESISTANCE IN PATIENTS OF UNIVENTRICULAR HEMODYNAMICS | 2004 |
|
RU2272295C2 |
| METHOD FOR ANALYZING HEMOGLOBIN AFFINITY TO OXYGEN | 0 |
|
SU1711225A1 |
| INFUSION SOLUTION | 2019 |
|
RU2708389C1 |
| METHOD OF EVALUATING SEVERITY OF ACUTE OPIOID POISONING | 2009 |
|
RU2413944C1 |
| SUBSTANCE SHOWING ANTIHYPOXIC AND ANTIHYPOTHERMIC PROPERTIES | 1983 |
|
SU1832499A3 |
| 2,6-DIMETHYL-3,5-BIS-(1-ADAMANTYLOXYCARONYL)-4-(2-DIFLUORMETHOXYPHENYL)-1,4-DIHYDROPYRIDINE POSSESSING ANTIANGINE EFFECT | 0 |
|
SU1044001A1 |
